Portal de investigación
Management of patients with primary biliary cholangitis in the post-obeticholic era: real-world effectiveness data on elafibranor and seladelpar from the ColHai registry
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Diaz-Gonzalez, A
- Montón, C
- Brosell, M
- Castiella, A
- Torrente, S
- Garcia-Retortillo, M
- Villagrasa, A
- Barciela, MR
- Gómez-Dominguez, E
- Almeida, AA
- Del Barrio, M
- Evole, HH
- Rodriguez-Tajes, S
- Monescillo, A
- Cortes, MG
- Ortiz, JPT
- Sousa-Martin, JM
- Herrojo, JA
- Moya, AG
- Alarcón, FC
- Casado-Martin, M
- Mateu, AR
- Hernández-Guerra, M
- Rios, MP
- Medrano, IP
- Quiñones, R
- Vega, LA
- Martinez, IE
- Bernal, V
- Bonilla, EF
- Fernandez-Rodriguez, C
- Diaz, R
- Vidal, M
- Lapeña, B
- De la Cruz, G
- Castello, I
- Gimeno, NG
- Plaza, MS
- Fernández-Yunquera, A
- Llinás, MS
- Fernández-Bermejo, M
- Trias, M
- Muñoz, BM
- Conejero, MDA
- León, RR
- Dueñas-Sánchez, E
- Prieto, J
- Vergara, M
- Londoño, MC
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Cita
Diaz,A,Montón,C,Brosell,M,Castiella,A,Torrente,S,Garcia,M,Villagrasa,A et al. Management of patients with primary biliary cholangitis in the post-obeticholic era: real-world effectiveness data on elafibranor and seladelpar from the ColHai registry. Congress of the European-Association-for-the-Study-of-the-Liver Congress (EASL). 2026. Barcelona. RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS:ELSEVIER. 2026 p.p. 16-16.